Brexit

Your IP Rights in Europe post Brexit

From 1 January 2021 the UK will no longer be part of EU IP systems. UK intellectual property rights will now co-exist alongside EU and national IP systems in Europe and the European Union.

As a European firm, HGF will continue to advise and to act for our clients in all aspects of patents, trade marks and designs across Europe. HGF will work with our clients to put in place strategies to address the changing IP landscape in Europe.

The headline points

The headline points to note in respect of IP rights post-Brexit are that:

  • UK national IP Rights will not be affected by the UKโ€™s exit from EU
  • Patents obtained via the EPO (which is not an EU institution) will not be affected by UK exit from the EU
  • Comparable UK trade mark and design rights will be created under the terms of the Withdrawal Agreement. On 1 January 2021, the UKIPO created a comparable UK trade mark and design for every registered EU trade mark (EUTM) and Registered Community design (RCD).

HGF continue to represent clients for all matters before the EPO and EUIPO in respect of European IP rights, as well as before national IP offices where we operate.

If you have any questions or concerns about IP Rights, or would like further advice on this matter, pleaseย contact your usual HGF attorney.

Discover the Brexit impact on:

Trade marks
Patents
The UPC
Designs

Latest News

Event - 11th November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Event details

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Read article

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Read article

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Read article
Event - 4th November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Event details
Event - 30th - 31st October 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Event details

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our specialists.

Contact us